New super-antibiotic
August 1, 2016
GERMAN scientists have
isolated the gene responsible
for staphylococcus lugdunensis’
ability to suppress staphylococcus
aureus, the dreaded ‘golden staph’
organism, or multiply resistant
staph aureus (MRSA), opening the
way to create a new antibiotic,
which they have dubbed lugdunin.
Tests on mice showed lugdunin
could treat superbug infections on
the skin including MRSA, as well as
enterococcal infections.
Staph lugdunensis was found
in the noses of humans who had
no staph aureus, and researchers
believe the body is host to a large
number of potential antibiotics.
“It is possible that this report will
be the first of many demonstrating
that bacteria in our bodies can
produce novel antibiotics with new
chemical structures,” researchers
said, according to the BBC.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Aug 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Aug 16
